ANWENDUNG DES HUMANBLUT-KOAGULATIONSFAKTORS-XIII ZUR BEHANDLUNG VON COLITIS GRAVIS
The use of human blood coagulation factor XIII for the treatment of ulcerative colitis is demonstrated in 4 representative cases. Treatment with factor XIII leads to rapid and total disappearance of the chief symptoms realizing transition to the remission stage.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | German |
Published |
19.05.1993
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The use of human blood coagulation factor XIII for the treatment of ulcerative colitis is demonstrated in 4 representative cases. Treatment with factor XIII leads to rapid and total disappearance of the chief symptoms realizing transition to the remission stage. |
---|---|
Bibliography: | Application Number: DE19883876817T |